Melanoma

Featured

Research Report
Pediatric Sunscreen Coverage by Medicaid as a Primary Prevention Strategy to Reduce Melanoma Burden: A Cost-Effectiveness Analysis
Dawn Queen, MD, and colleagues developed a model testing the hypothesis that New York State Medicaid coverage of sunscreen for pediatric beneficiaries is a cost-effective strategy…
Quiz
Quiz: Immune Checkpoint Inhibitors (ICIs) in Cutaneous Metastatic Melanoma
True or False: While ICIs are successful in treating advanced melanoma, ICIs show no efficacy in treating cutaneous…
Quiz
Quiz: Medicare Fee-for-Service Pricing Impact on Skin Cancer Procedures
True or False: Medicare fee-for-service pricing incentivizes use of Mohs micrographic surgery over other skin cancer…
News
Medicare FFS Pricing Incentivizes Use of Mohs Micrographic Surgery Over Other Skin Cancer Procedures
Study results show Medicare payment rates for Mohs micrographic surgery more than double those of other procedures for…
News
Real-World Effectiveness of ICIs for Older Patients With Advanced Melanoma
Immune checkpoint inhibitor therapy deliver in a real-world setting significantly improves survival in patients aged 65…

News

Medicare FFS Pricing Incentivizes Use of Mohs Micrographic Surgery Over Other Skin Cancer Procedures
Real-World Effectiveness of ICIs for Older Patients With Advanced Melanoma
Predictive Value of Circulating Tumor DNA in Melanoma Patients After First-Line Treatment With ICIs
Adjuvant Pembrolizumab Improves RFS in High-Risk Melanoma

Guideline Updates

ASCO Updates Systemic Therapy Guideline for Melanoma
Back to Top